1. “Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics”
by Valentina Tateo, Paola Valeria Marchese, Veronica Mollica, Francesco Massari, Razelle Kurzrock and Jacob J. Adashek
Pharmaceuticals 2023, 16(4), 614; https://doi.org/10.3390/ph16040614
Available online: https://www.mdpi.com/1424-8247/16/4/614
2. “A Scoping Review and Meta-Analysis of Anti-CGRP Monoclonal Antibodies: Predicting Response”
by Ja Bin Hong, Kristin Sophie Lange, Lucas Hendrik Overeem, Paul Triller, Bianca Raffaelli and Uwe Reuter
Pharmaceuticals 2023, 16(7), 934; https://doi.org/10.3390/ph16070934
Available online: https://www.mdpi.com/1424-8247/16/7/934
3. “Pharmacological Activities of Schiff Bases and Their Derivatives with Low and High Molecular Phosphonates”
by Ivelina Tsacheva, Zornica Todorova, Denitsa Momekova, Georgi Momekov and Neli Koseva
Pharmaceuticals 2023, 16(7), 938; https://doi.org/10.3390/ph16070938
Available online: https://www.mdpi.com/1424-8247/16/7/938
4. “Advances and Challenges in Targeting TGF-β Isoforms for Therapeutic Intervention of Cancer: A Mechanism-Based Perspective”
by David Danielpour
Pharmaceuticals 2024, 17(4), 533; https://doi.org/10.3390/ph17040533
Available online: https://www.mdpi.com/1424-8247/17/4/533
5. “Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database”
by Rosanna Ruggiero, Annamaria Mascolo, Angela Spezzaferri, Claudia Carpentieri, Daniele Torella, Liberata Sportiello, Francesco Rossi, Giuseppe Paolisso and Annalisa Capuano
Pharmaceuticals 2024, 17(2), 147; https://doi.org/10.3390/ph17020147
Available online: https://www.mdpi.com/1424-8247/17/2/147
